Skip to main content
Erschienen in: Quality of Life Research 10/2022

30.07.2022 | Editorial

Introduction to the special section "Reducing research waste in (health-related) quality of life research"

verfasst von: Claudia Rutherford, Jan R. Boehnke

Erschienen in: Quality of Life Research | Ausgabe 10/2022

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Excerpt

In 2021, we issued a call for papers on reducing (health-related) quality of life ((HR)QL) research waste and optimizing patient-reported outcome (PRO)/(HR)QL data. As identified by Chalmers and Glasziou [1], research waste refers to avoidable inappropriate conduct and dissemination of research. It has multiple contributing factors and is likely a spectrum of impact rather than a dichotomous categorization (e.g., a question of how much of a given study could be considered research waste). In particular, Chalmers and Glasziou highlighted "the choice of research questions; the quality of research design and methods; the adequacy of publication practices; and the quality of reports of research" [2] as focal areas where decisions and actions of stakeholders in the research process could have negative impact. …

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Glasziou, P., & Chalmers, I. (2018). Research waste is still a scandal—An essay by Paul Glasziou and Iain Chalmers. BMJ, 363, k4645.CrossRef Glasziou, P., & Chalmers, I. (2018). Research waste is still a scandal—An essay by Paul Glasziou and Iain Chalmers. BMJ, 363, k4645.CrossRef
2.
Zurück zum Zitat Chalmers, I., & Glasziou, P. (2009). Avoidable waste in the production and reporting of research evidence. The Lancet, 374(9683), 86–89.CrossRef Chalmers, I., & Glasziou, P. (2009). Avoidable waste in the production and reporting of research evidence. The Lancet, 374(9683), 86–89.CrossRef
3.
Zurück zum Zitat Cruz Rivera, S., McMullan, C., Jones, L., Kyte, D., Slade, A., & Calvert, M. (2020). The impact of patient-reported outcome data from clinical trials: Perspectives from international stakeholders. Journal of Patient-Reported Outcomes., 4(1), 51.PubMedPubMedCentralCrossRef Cruz Rivera, S., McMullan, C., Jones, L., Kyte, D., Slade, A., & Calvert, M. (2020). The impact of patient-reported outcome data from clinical trials: Perspectives from international stakeholders. Journal of Patient-Reported Outcomes., 4(1), 51.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Mercieca-Bebber, R., Friedlander, M., Calvert, M., Stockler, M., Kyte, D., Kok, P.-S., et al. (2017). A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: Implications for generalisability and clinical practice. Journal of Patient-Reported Outcomes, 1(1), 5.PubMedPubMedCentralCrossRef Mercieca-Bebber, R., Friedlander, M., Calvert, M., Stockler, M., Kyte, D., Kok, P.-S., et al. (2017). A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: Implications for generalisability and clinical practice. Journal of Patient-Reported Outcomes, 1(1), 5.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Haywood, K., Lyddiatt, A., Brace-McDonnell, S. J., Staniszewska, S., & Salek, S. (2017). Establishing the values for patient engagement (PE) in health-related quality of life (HRQoL) research: An international, multiple-stakeholder perspective. Quality of Life Research, 26(6), 1393–1404.PubMedCrossRef Haywood, K., Lyddiatt, A., Brace-McDonnell, S. J., Staniszewska, S., & Salek, S. (2017). Establishing the values for patient engagement (PE) in health-related quality of life (HRQoL) research: An international, multiple-stakeholder perspective. Quality of Life Research, 26(6), 1393–1404.PubMedCrossRef
6.
Zurück zum Zitat Mercieca-Bebber, R., Rouette, J., Calvert, M., King, M. T., McLeod, L., Holch, P., et al. (2017). Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension. Quality of Life Research, 26(6), 1427–1437.PubMedCrossRef Mercieca-Bebber, R., Rouette, J., Calvert, M., King, M. T., McLeod, L., Holch, P., et al. (2017). Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension. Quality of Life Research, 26(6), 1427–1437.PubMedCrossRef
7.
Zurück zum Zitat Haywood, K. L., Brett, J., Tutton, E., & Staniszewska, S. (2017). Patient-reported outcome measures in older people with hip fracture: A systematic review of quality and acceptability. Quality of Life Research, 26(4), 799–812.PubMedCrossRef Haywood, K. L., Brett, J., Tutton, E., & Staniszewska, S. (2017). Patient-reported outcome measures in older people with hip fracture: A systematic review of quality and acceptability. Quality of Life Research, 26(4), 799–812.PubMedCrossRef
8.
Zurück zum Zitat Calvert, M., King, M., & Brundage, M. (2018). Minimising research waste and maximising the impact of patient reported outcome trial results. Quality of Life Research, 27, S3. Calvert, M., King, M., & Brundage, M. (2018). Minimising research waste and maximising the impact of patient reported outcome trial results. Quality of Life Research, 27, S3.
9.
Zurück zum Zitat Macleod, M. R., Michie, S., Roberts, I., Dirnagl, U., Chalmers, I., Ioannidis, J. P., et al. (2014). Biomedical research: Increasing value, reducing waste. The Lancet, 383(9912), 101–104.CrossRef Macleod, M. R., Michie, S., Roberts, I., Dirnagl, U., Chalmers, I., Ioannidis, J. P., et al. (2014). Biomedical research: Increasing value, reducing waste. The Lancet, 383(9912), 101–104.CrossRef
10.
Zurück zum Zitat Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., et al. (2014). Reducing waste from incomplete or unusable reports of biomedical research. The Lancet, 383(9913), 267–276.CrossRef Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., et al. (2014). Reducing waste from incomplete or unusable reports of biomedical research. The Lancet, 383(9913), 267–276.CrossRef
12.
Zurück zum Zitat Ioannidis, J. P., Greenland, S., Hlatky, M. A., Khoury, M. J., Macleod, M. R., Moher, D., et al. (2014). Increasing value and reducing waste in research design, conduct, and analysis. The Lancet, 383(9912), 166–175.CrossRef Ioannidis, J. P., Greenland, S., Hlatky, M. A., Khoury, M. J., Macleod, M. R., Moher, D., et al. (2014). Increasing value and reducing waste in research design, conduct, and analysis. The Lancet, 383(9912), 166–175.CrossRef
13.
Zurück zum Zitat Kyte, D., Duffy, H., Fletcher, B., Gheorghe, A., Mercieca-Bebber, R., King, M., et al. (2014). Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols. PLoS ONE, 9(10), e110229.PubMedPubMedCentralCrossRef Kyte, D., Duffy, H., Fletcher, B., Gheorghe, A., Mercieca-Bebber, R., King, M., et al. (2014). Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols. PLoS ONE, 9(10), e110229.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Kyte, D., Retzer, A., Ahmed, K., Keeley, T., Armes, J., Brown, J. M., et al. (2019). Systematic evaluation of patient-reported outcome protocol content and reporting in cancer trials. Journal of the National Cancer Institute, 111(11), 1170–1178.PubMedPubMedCentralCrossRef Kyte, D., Retzer, A., Ahmed, K., Keeley, T., Armes, J., Brown, J. M., et al. (2019). Systematic evaluation of patient-reported outcome protocol content and reporting in cancer trials. Journal of the National Cancer Institute, 111(11), 1170–1178.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Mercieca-Bebber, R., Friedlander, M., Kok, P. S., Calvert, M., Kyte, D., Stockler, M., et al. (2016). The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols. Quality of Life Research, 25(10), 2457–2465.PubMedCrossRef Mercieca-Bebber, R., Friedlander, M., Kok, P. S., Calvert, M., Kyte, D., Stockler, M., et al. (2016). The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols. Quality of Life Research, 25(10), 2457–2465.PubMedCrossRef
16.
Zurück zum Zitat Calvert, M., King, M., Mercieca-Bebber, R., Aiyegbusi, O., Kyte, D., Slade, A., et al. (2021). SPIRIT-PRO Extension explanation and elaboration: Guidelines for inclusion of patient-reported outcomes in protocols of clinical trials. British Medical Journal Open, 11(6), e045105. Calvert, M., King, M., Mercieca-Bebber, R., Aiyegbusi, O., Kyte, D., Slade, A., et al. (2021). SPIRIT-PRO Extension explanation and elaboration: Guidelines for inclusion of patient-reported outcomes in protocols of clinical trials. British Medical Journal Open, 11(6), e045105.
17.
Zurück zum Zitat Calvert, M., Kyte, D., Mercieca-Bebber, R., Slade, A., Chan, A. W., King, M. T., et al. (2018). Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The SPIRIT-PRO extension. JAMA, 319(5), 483–494.PubMedCrossRef Calvert, M., Kyte, D., Mercieca-Bebber, R., Slade, A., Chan, A. W., King, M. T., et al. (2018). Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The SPIRIT-PRO extension. JAMA, 319(5), 483–494.PubMedCrossRef
20.
Zurück zum Zitat Calvert, M., Blazeby, J., Altman, D. G., Revicki, D. A., Moher, D., & Brundage, M. D. (2013). Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension. JAMA, 309(8), 814–822.PubMedCrossRef Calvert, M., Blazeby, J., Altman, D. G., Revicki, D. A., Moher, D., & Brundage, M. D. (2013). Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension. JAMA, 309(8), 814–822.PubMedCrossRef
22.
Zurück zum Zitat Mercieca-Bebber, R., Friedlander, M., Calvert, M., Stockler, M., Kyte, D., Kok, P. S., et al. (2017). A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: Implications for generalisability and clinical practice. J Patient Rep Outcomes, 1(1), 5.PubMedPubMedCentralCrossRef Mercieca-Bebber, R., Friedlander, M., Calvert, M., Stockler, M., Kyte, D., Kok, P. S., et al. (2017). A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: Implications for generalisability and clinical practice. J Patient Rep Outcomes, 1(1), 5.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Mercieca-Bebber, R. L., Perreca, A., King, M., Macann, A., Whale, K., Soldati, S., et al. (2016). Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation. European Journal of Cancer, 56, 144–161.PubMedCrossRef Mercieca-Bebber, R. L., Perreca, A., King, M., Macann, A., Whale, K., Soldati, S., et al. (2016). Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation. European Journal of Cancer, 56, 144–161.PubMedCrossRef
26.
Zurück zum Zitat Chan, A. W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P. C., et al. (2014). Increasing value and reducing waste: Addressing inaccessible research. The Lancet, 383(9913), 257–266.CrossRef Chan, A. W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P. C., et al. (2014). Increasing value and reducing waste: Addressing inaccessible research. The Lancet, 383(9913), 257–266.CrossRef
27.
Zurück zum Zitat Rutherford, C., Müller, F., Faiz, N., King, M. T., & White, K. (2020). Patient-reported outcomes and experiences from the perspective of colorectal cancer survivors: Meta-synthesis of qualitative studies. J Patient Reported Outcomes, 4(1), 27.CrossRef Rutherford, C., Müller, F., Faiz, N., King, M. T., & White, K. (2020). Patient-reported outcomes and experiences from the perspective of colorectal cancer survivors: Meta-synthesis of qualitative studies. J Patient Reported Outcomes, 4(1), 27.CrossRef
28.
Zurück zum Zitat Rutherford, C., Patel, M. I., Tait, M. A., Smith, D. P., Costa, D. S. J., Sengupta, S., et al. (2021). Patient-reported outcomes in non-muscle invasive bladder cancer: A mixed-methods systematic review. Quality of Life Research, 30(2), 345–366.PubMedCrossRef Rutherford, C., Patel, M. I., Tait, M. A., Smith, D. P., Costa, D. S. J., Sengupta, S., et al. (2021). Patient-reported outcomes in non-muscle invasive bladder cancer: A mixed-methods systematic review. Quality of Life Research, 30(2), 345–366.PubMedCrossRef
29.
Zurück zum Zitat King, M. T., Winters, Z. E., Olivotto, I. A., Spillane, A. J., Chua, B. H., Saunders, C., et al. (2017). Patient-reported outcomes in ductal carcinoma in situ: A systematic review. European Journal of Cancer, 71, 95–108.PubMedCrossRef King, M. T., Winters, Z. E., Olivotto, I. A., Spillane, A. J., Chua, B. H., Saunders, C., et al. (2017). Patient-reported outcomes in ductal carcinoma in situ: A systematic review. European Journal of Cancer, 71, 95–108.PubMedCrossRef
34.
Zurück zum Zitat Al-Shahi Salman, R., Beller, E., Kagan, J., Hemminki, E., Phillips, R. S., Savulescu, J., et al. (2014). Increasing value and reducing waste in biomedical research regulation and management. Lancet, 383(9912), 176–185.PubMedCrossRef Al-Shahi Salman, R., Beller, E., Kagan, J., Hemminki, E., Phillips, R. S., Savulescu, J., et al. (2014). Increasing value and reducing waste in biomedical research regulation and management. Lancet, 383(9912), 176–185.PubMedCrossRef
36.
Zurück zum Zitat Chalmers, I., Bracken, M. B., Djulbegovic, B., Garattini, S., Grant, J., Gülmezoglu, A. M., et al. (2014). How to increase value and reduce waste when research priorities are set. Lancet, 383(9912), 156–165.PubMedCrossRef Chalmers, I., Bracken, M. B., Djulbegovic, B., Garattini, S., Grant, J., Gülmezoglu, A. M., et al. (2014). How to increase value and reduce waste when research priorities are set. Lancet, 383(9912), 156–165.PubMedCrossRef
38.
Zurück zum Zitat Costa, D. S. J., Mercieca-Bebber, R., Rutherford, C., Tait, M.-A., & King, M. T. (2021). How is quality of life defined and assessed in published research? Quality of Life Research, 30(8), 2109–2121.PubMedCrossRef Costa, D. S. J., Mercieca-Bebber, R., Rutherford, C., Tait, M.-A., & King, M. T. (2021). How is quality of life defined and assessed in published research? Quality of Life Research, 30(8), 2109–2121.PubMedCrossRef
39.
Zurück zum Zitat Skevington, S. M., & Böhnke, J. R. (2018). How is subjective well-being related to quality of life? Do we need two concepts and both measures? Social Science & Medicine, 206, 22–30.CrossRef Skevington, S. M., & Böhnke, J. R. (2018). How is subjective well-being related to quality of life? Do we need two concepts and both measures? Social Science & Medicine, 206, 22–30.CrossRef
40.
Zurück zum Zitat Haraldstad, K., Wahl, A., Andenæs, R., Andersen, J. R., Andersen, M. H., Beisland, E., et al. (2019). A systematic review of quality of life research in medicine and health sciences. Quality of Life Research, 28(10), 2641–2650.PubMedPubMedCentralCrossRef Haraldstad, K., Wahl, A., Andenæs, R., Andersen, J. R., Andersen, M. H., Beisland, E., et al. (2019). A systematic review of quality of life research in medicine and health sciences. Quality of Life Research, 28(10), 2641–2650.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273(1), 59–65.PubMedCrossRef Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273(1), 59–65.PubMedCrossRef
44.
Zurück zum Zitat Hays, R. D., & Fayers, P. M. (2021). Overlap of depressive symptoms with health-related quality-of-life measures. PharmacoEconomics, 39(6), 627–630.PubMedCrossRef Hays, R. D., & Fayers, P. M. (2021). Overlap of depressive symptoms with health-related quality-of-life measures. PharmacoEconomics, 39(6), 627–630.PubMedCrossRef
45.
Zurück zum Zitat van Zyl, L. E., & Rothmann, S. (2022). Grand challenges for positive psychology: Future perspectives and opportunities. Frontiers in Psychology, 13, 1–8. van Zyl, L. E., & Rothmann, S. (2022). Grand challenges for positive psychology: Future perspectives and opportunities. Frontiers in Psychology, 13, 1–8.
46.
Zurück zum Zitat Marsh, H. W. (1994). Sport motivation orientations: Beware of jingle-jangle fallacies. Journal of Sport and Exercise Psychology, 16(4), 365–380.CrossRef Marsh, H. W. (1994). Sport motivation orientations: Beware of jingle-jangle fallacies. Journal of Sport and Exercise Psychology, 16(4), 365–380.CrossRef
47.
Zurück zum Zitat Minogue, V., Cooke, M., Donskoy, A.-L., Vicary, P., & Wells, B. (2018). Patient and public involvement in reducing health and care research waste. Research Involvement and Engagement, 4(1), 5.PubMedPubMedCentralCrossRef Minogue, V., Cooke, M., Donskoy, A.-L., Vicary, P., & Wells, B. (2018). Patient and public involvement in reducing health and care research waste. Research Involvement and Engagement, 4(1), 5.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Mercieca-Bebber, R., Palmer, M. J., Brundage, M., Calvert, M., Stockler, M. R., & King, M. T. (2016). Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: A systematic review. British Medical Journal Open, 6(6), e010938. Mercieca-Bebber, R., Palmer, M. J., Brundage, M., Calvert, M., Stockler, M. R., & King, M. T. (2016). Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: A systematic review. British Medical Journal Open, 6(6), e010938.
49.
Zurück zum Zitat Bell, M. L., & Fairclough, D. L. (2014). Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Statistical Methods in Medical Research, 23(5), 440–459.PubMedCrossRef Bell, M. L., & Fairclough, D. L. (2014). Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Statistical Methods in Medical Research, 23(5), 440–459.PubMedCrossRef
50.
Zurück zum Zitat Molenberghs, G., Fitzmaurice, G., Kenward, M. G., Tsiatis, A., & Verbeke, G. (Eds.). (2015). Handbook of missing data methodology (1st ed.). Chapman and Hall CRC. Molenberghs, G., Fitzmaurice, G., Kenward, M. G., Tsiatis, A., & Verbeke, G. (Eds.). (2015). Handbook of missing data methodology (1st ed.). Chapman and Hall CRC.
51.
Zurück zum Zitat van Buuren, S. (2018). Flexible imputation of missing data. Chapman and Hall/CRC.CrossRef van Buuren, S. (2018). Flexible imputation of missing data. Chapman and Hall/CRC.CrossRef
52.
Zurück zum Zitat Boehnke, J. R., & Rutherford, C. (2020). Registered Reports at “Quality of life research.” Quality of Life Research, 29(10), 2605–2607.PubMedCrossRef Boehnke, J. R., & Rutherford, C. (2020). Registered Reports at “Quality of life research.” Quality of Life Research, 29(10), 2605–2607.PubMedCrossRef
53.
Zurück zum Zitat Coens, C., Pe, M., Dueck, A. C., Sloan, J., Basch, E., Calvert, M., et al. (2020). International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: Recommendations of the SISAQOL Consortium. The Lancet Oncology, 21(2), e83–e96.PubMedCrossRef Coens, C., Pe, M., Dueck, A. C., Sloan, J., Basch, E., Calvert, M., et al. (2020). International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: Recommendations of the SISAQOL Consortium. The Lancet Oncology, 21(2), e83–e96.PubMedCrossRef
54.
Zurück zum Zitat Qian, Y., Walters, S. J., Jacques, R., & Flight, L. (2021). Comprehensive review of statistical methods for analysing patient-reported outcomes (PROs) used as primary outcomes in randomised controlled trials (RCTs) published by the UK’s Health Technology Assessment (HTA) journal (1997–2020). British Medical Journal Open, 11(9), e051673. Qian, Y., Walters, S. J., Jacques, R., & Flight, L. (2021). Comprehensive review of statistical methods for analysing patient-reported outcomes (PROs) used as primary outcomes in randomised controlled trials (RCTs) published by the UK’s Health Technology Assessment (HTA) journal (1997–2020). British Medical Journal Open, 11(9), e051673.
55.
Zurück zum Zitat Arnold, K. F., Harrison, W. J., Heppenstall, A. J., & Gilthorpe, M. S. (2018). DAG-informed regression modelling, agent-based modelling and microsimulation modelling: A critical comparison of methods for causal inference. International Journal of Epidemiology., 48(1), 243–253.PubMedCentralCrossRef Arnold, K. F., Harrison, W. J., Heppenstall, A. J., & Gilthorpe, M. S. (2018). DAG-informed regression modelling, agent-based modelling and microsimulation modelling: A critical comparison of methods for causal inference. International Journal of Epidemiology., 48(1), 243–253.PubMedCentralCrossRef
56.
Zurück zum Zitat Little, R. J., & Rubin, D. B. (2000). Causal effects in clinical and epidemiological studies via potential outcomes: Concepts and analytical approaches. Annual Review of Public Health., 21(1), 121–145.PubMedCrossRef Little, R. J., & Rubin, D. B. (2000). Causal effects in clinical and epidemiological studies via potential outcomes: Concepts and analytical approaches. Annual Review of Public Health., 21(1), 121–145.PubMedCrossRef
57.
Zurück zum Zitat Rubin, D. B. (2010). On the limitations of comparative effectiveness research. Statistics in Medicine, 29(19), 1991–1995.PubMedCrossRef Rubin, D. B. (2010). On the limitations of comparative effectiveness research. Statistics in Medicine, 29(19), 1991–1995.PubMedCrossRef
58.
Zurück zum Zitat Angrist, J. D., & Pischke, J.-S. (2009). Mostly Harmless Econometrics: An Empiricist’s Companion. Princeford University Press.CrossRef Angrist, J. D., & Pischke, J.-S. (2009). Mostly Harmless Econometrics: An Empiricist’s Companion. Princeford University Press.CrossRef
60.
Zurück zum Zitat Mercieca-Bebber, R., King, M. T., Calvert, M. J., Stockler, M. R., & Friedlander, M. (2018). The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Related Outcome Measures, 9, 353–367.PubMedPubMedCentralCrossRef Mercieca-Bebber, R., King, M. T., Calvert, M. J., Stockler, M. R., & Friedlander, M. (2018). The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Related Outcome Measures, 9, 353–367.PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Simmons, J. P., Nelson, L. D., & Simonsohn, U. (2011). False-positive psychology: Undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychological Science, 22(11), 1359–1366.PubMedCrossRef Simmons, J. P., Nelson, L. D., & Simonsohn, U. (2011). False-positive psychology: Undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychological Science, 22(11), 1359–1366.PubMedCrossRef
62.
Zurück zum Zitat Kerr, N. L. (1998). HARKing: Hypothesizing after the results are known. Personality and Social Psychology Review, 2(3), 196–217.PubMedCrossRef Kerr, N. L. (1998). HARKing: Hypothesizing after the results are known. Personality and Social Psychology Review, 2(3), 196–217.PubMedCrossRef
63.
Zurück zum Zitat Luckett, T., & King, M. T. (2010). Choosing patient-reported outcome measures for cancer clinical research–practical principles and an algorithm to assist non-specialist researchers. European Journal of Cancer, 46(18), 3149–3157.PubMedCrossRef Luckett, T., & King, M. T. (2010). Choosing patient-reported outcome measures for cancer clinical research–practical principles and an algorithm to assist non-specialist researchers. European Journal of Cancer, 46(18), 3149–3157.PubMedCrossRef
64.
Zurück zum Zitat Snyder, C. F., Watson, M. E., Jackson, J. D., Cella, D., & Halyard, M. Y. (2007). Patient-reported outcome instrument selection: Designing a measurement strategy. Value Health., 10(Suppl 2), S76-85.PubMedCrossRef Snyder, C. F., Watson, M. E., Jackson, J. D., Cella, D., & Halyard, M. Y. (2007). Patient-reported outcome instrument selection: Designing a measurement strategy. Value Health., 10(Suppl 2), S76-85.PubMedCrossRef
66.
67.
Zurück zum Zitat Fang, F. C., Bowen, A., & Casadevall, A. (2016). NIH peer review percentile scores are poorly predictive of grant productivity. eLife, 5, e13323.PubMedPubMedCentralCrossRef Fang, F. C., Bowen, A., & Casadevall, A. (2016). NIH peer review percentile scores are poorly predictive of grant productivity. eLife, 5, e13323.PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Aczel, B., Szaszi, B., & Holcombe, A. O. (2021). A billion-dollar donation: Estimating the cost of researchers’ time spent on peer review. Research Integrity and Peer Review., 6(1), 14.PubMedPubMedCentralCrossRef Aczel, B., Szaszi, B., & Holcombe, A. O. (2021). A billion-dollar donation: Estimating the cost of researchers’ time spent on peer review. Research Integrity and Peer Review., 6(1), 14.PubMedPubMedCentralCrossRef
69.
70.
Zurück zum Zitat Ashuntantang, G., Luyckx, V., Naicker, S., & Venkatapuram, S. (2021). Reform of research funding processes could pave the way for progress in global health. The Lancet Global Health., 9(8), e1053–e1054.PubMedCrossRef Ashuntantang, G., Luyckx, V., Naicker, S., & Venkatapuram, S. (2021). Reform of research funding processes could pave the way for progress in global health. The Lancet Global Health., 9(8), e1053–e1054.PubMedCrossRef
71.
Zurück zum Zitat Bekele, A., Chu, K., D’Ambruoso, L., Davies, J. I., Ferriolli, E., Greig, C., et al. (2022). Global health research funding applications: Brain drain under another name? The Lancet Global Health., 10(1), e22–e23.PubMedCrossRef Bekele, A., Chu, K., D’Ambruoso, L., Davies, J. I., Ferriolli, E., Greig, C., et al. (2022). Global health research funding applications: Brain drain under another name? The Lancet Global Health., 10(1), e22–e23.PubMedCrossRef
72.
Zurück zum Zitat Olusanya, J. O., Ubogu, O. I., Njokanma, F. O., & Olusanya, B. O. (2021). Transforming global health through equity-driven funding. Nature Medicine, 27(7), 1136–1138.PubMedCrossRef Olusanya, J. O., Ubogu, O. I., Njokanma, F. O., & Olusanya, B. O. (2021). Transforming global health through equity-driven funding. Nature Medicine, 27(7), 1136–1138.PubMedCrossRef
73.
Zurück zum Zitat Rutherford, C., & Böhnke J.R. (2022). Introduction to the Special Section Reducing Research Waste in (Health-Related) Quality of Life Research. Retrieved from psyarxiv.com/879xp Rutherford, C., & Böhnke J.R. (2022). Introduction to the Special Section Reducing Research Waste in (Health-Related) Quality of Life Research. Retrieved from psyarxiv.com/879xp
Metadaten
Titel
Introduction to the special section "Reducing research waste in (health-related) quality of life research"
verfasst von
Claudia Rutherford
Jan R. Boehnke
Publikationsdatum
30.07.2022
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 10/2022
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-022-03194-z

Weitere Artikel der Ausgabe 10/2022

Quality of Life Research 10/2022 Zur Ausgabe

Special Section: Reducing Research Waste in (Health-Related) Quality of Life Research

Challenges and opportunities for using population health data to investigate cancer survivors’ quality of life in Australia

Special Section: Reducing Research Waste in (Health-Related) Quality of Life Research

Reducing waste in collection of quality-of-life data through better reporting: a case study

Premium Partner